MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2023

Nov 5, 2023

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

6 November 2023

ASX Market Announcements ASX Limited Level 4, North Tower, Rialto 525 Collins Street Melbourne VIC 3000

Section 708A Cleansing Notice

Mach7 Technologies Limited (“M7T” or “the Company”) (ASX:M7T) gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (“Corporations Act”) as follows:

• (a) On 1 November 2023 the Company issued 225,000 fully paid ordinary shares at an issue price of $0.244 per share upon the exercise of options.

• (b) The shares were issued without disclosure to the investors under Part 6D.2 of the Corporations Act.

• (c) This notice is provided under paragraph 5(e) of Section 708A of the Corporations Act.

• (d) As at the date of this notice the Company has complied with:

• (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

• (ii) Sections 674 and 674Aof the Corporations Act.

• (e) As at the date of this notice there is no excluded information required to be disclosed under section 708A(7) and 708A(8) of the Corporations Act.

An Appendix 2A relating to the issue of Shares noted above will be lodged shortly.

For more information, contact:

Investor Relations

Françoise Dixon +61 (0) 412 292 977 ir@mach7t.com

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222

www.mach7t.com

==> picture [104 x 26] intentionally omitted <==

ASX Announcement

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T), founded in 2007, is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organizations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Departmental Workflow applications. eUnity is a zero-footprint, FDAapproved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. With more than 165 customers across 15 different countries, Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com